Produkty 97653-94-6

CAS 97653-94-6 występuje w naszej ofercie pod nazwami: Ganoderic acid D2, Ganoderic acid D2, Ganoderic acid D2, 99.69%, Ganoderic acid D2, ≥95%. Oferty producentów: GLPBio, Biosynth, MedChemExpress, Chemat. Dostępne opakowania: 1mg, 5mg, 2mg, 25mg, 10mg, 1 mg, 5 mg, 10 mg.

Ganoderic acid D2
GLPBio
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 1256,99
Zobacz produkt
Ganoderic acid D2
Biosynth
  • opakowanie: 1mg, 2mg, 5mg, 25mg
  • Warianty: 5
Zobacz produkt
Ganoderic acid D2, 99.69%
MedChemExpress
  • opakowanie: 1 mg, 5 mg, 10 mg
  • Warianty: 3
od 1081,31
Zobacz produkt
Ganoderic acid D2, ≥95%
Chemat
  • opakowanie: 2mg
  • Warianty: 1
od 2282,00
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(6R)-6-[(5R,7S,10S,12S,13R,14R,17R)-7,12-dihydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid (CAS 97653-94-6) to związek chemiczny o wzorze sumarycznym C30H42O8 i masie molowej 530.6 g/mol. Nazwa systematyczna IUPAC: (6R)-6-[(5R,7S,10S,12S,13R,14R,17R)-7,12-dihydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid. InChIKey: LCIUOVOXWPIXOR-OHISEBISSA-N.

Dane identyfikacyjne
Wzór sumarycznyC30H42O8
Masa molowa530.6 g/mol
Nazwa IUPAC(6R)-6-[(5R,7S,10S,12S,13R,14R,17R)-7,12-dihydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid
InChIKeyLCIUOVOXWPIXOR-OHISEBISSA-N
SMILESC[C@H](CC(=O)CC(C)C(=O)O)[C@H]1CC(=O)[C@@]2([C@@]1([C@@H](C(=O)C3=C2[C@H](C[C@@H]4[C@@]3(CCC(=O)C4(C)C)C)O)O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Ganoderic acid D2, GanodericacidD2, Ganoderic acid M, (+)-7|A,12|A-Dihydroxy-3,11,15,23-tetraoxolanosta-8-ene-26-oic acid
Powiązane formy tego związku
(6R)-6-[(7S,10S,12S,13R,14R,17R)-7,12-dihydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid C30H42O8
(6R)-6-[(5R,7S,10S,13R,14R,17R)-7,12-dihydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid C30H42O8
Izomery (ten sam wzór sumaryczny)
6-hydroxy-6-(7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid C30H42O8
5-[(3S,8R,9S,10R,13R,14S,17R)-14-hydroxy-10,13-dimethyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one C30H42O8
methyl (4R)-4-[(3S,5R,10S,12S,13R,14R,17R)-12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]pentanoate C30H42O8
(2R,6R)-6-[(3S,5S,10S,12S,13R,14R,17R)-3,12-dihydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid C30H42O8
3-[(1S,3R,7R,10R,11S,14S,16R)-14-[(2R,3R,4S,5S,6R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-5-en-6-yl]-2H-furan-5-one C30H42O8
(Z)-2-methyl-4-oxo-6-[(3S,5R,7S,10S,12S,13R,14R,17R)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-enoic acid C30H42O8
(Z)-2-methyl-4-oxo-6-[(3S,7S,10S,12S,13R,14R)-3,7,12-trihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-enoic acid C30H42O8